Statistics for Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
Total visits
| views | |
|---|---|
| Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study | 78 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 1 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Efficacy and safety of patisiran.pdf(legacy) | 71 |
| Efficacy and safety of patisiran.pdf | 5 |
Top country views
| views | |
|---|---|
| United States | 30 |
| China | 18 |
| Germany | 6 |
| Poland | 5 |
| Australia | 4 |
| United Kingdom | 4 |
| Portugal | 4 |
| Singapore | 2 |
| Canada | 1 |
| France | 1 |
| Hong Kong SAR China | 1 |
| India | 1 |
| Mongolia | 1 |
| Netherlands | 1 |
Top city views
| views | |
|---|---|
| Delhi | 1 |